Tazemetostat and Venetoclax in Relapsed/Refractory Non-Hodgkin Lymphoma
Weill Medical College of Cornell University
Weill Medical College of Cornell University
Novartis
MEI Pharma, Inc.
Atara Biotherapeutics
Massachusetts General Hospital
Century Therapeutics, Inc.
Boston University
Assistance Publique - Hôpitaux de Paris
University of Washington
Regeneron Pharmaceuticals
Roswell Park Cancer Institute
University of Washington
AbbVie
Adicet Therapeutics
Memorial Sloan Kettering Cancer Center
University of California, Davis
Celgene
Columbia University
Dana-Farber Cancer Institute
Janssen Research & Development, LLC
Zhejiang DTRM Biopharma
MEI Pharma, Inc.
Amgen
Fondazione Italiana Linfomi - ETS
MEI Pharma, Inc.
Genmab
Hoffmann-La Roche
Academic and Community Cancer Research United
Xenikos
Columbia University
TG Therapeutics, Inc.
IGM Biosciences, Inc.
MingSight Pharmaceuticals, Inc
AHS Cancer Control Alberta
Altor BioScience
University of California, San Francisco
University of Chicago
Ipsen
Amgen
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
BioNova Pharmaceuticals (Shanghai) LTD.
Prelude Therapeutics
Stanford University
ADC Therapeutics S.A.
SecuraBio
SecuraBio
University of Nebraska
University of Nebraska